Obesity-associated hyperinsulinemia may play an important role in endometrial cancer through a direct effect via the stimulation of endometrial cell proliferation or indirectly through sex steroid and insulin-like growth factor 1 pathways [2]. This evidence concerns the gene IGF1 and obesity due to melanocortin 4 receptor deficiency.